Susquehanna International Group, LLP Zai Lab LTD Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$16.25 - $24.14 $1.17 Million - $1.74 Million	-71,900 Reduced 46.36%	83,200 $2.01 Million
Q2 2024 Aug 15, 2024	BUY	$13.72 - $21.55 $982,352 - $1.54 Million	71,600 Added 85.75%	155,100 $2.69 Million
Q1 2024 May 07, 2024	BUY	$15.95 - $26.8 $614,075 - $1.03 Million	38,500 Added 85.56%	83,500 $1.34 Million
Q4 2023 Feb 14, 2024	BUY	$22.97 - $30.58 $709,773 - $944,922	30,900 Added 219.15%	45,000 $1.23 Million
Q3 2023 Nov 14, 2023	SELL	$22.72 - $31.49 $1.21 Million - $1.68 Million	-53,400 Reduced 79.11%	14,100 $342,000
Q2 2023 Aug 11, 2023	SELL	$25.3 - $39.67 $197,340 - $309,426	-7,800 Reduced 10.36%	67,500 $1.87 Million
Q1 2023 May 16, 2023	SELL	$30.21 - $48.1 $1.72 Million - $2.74 Million	-56,900 Reduced 43.04%	75,300 $2.5 Million
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $2.25 Million - $3.91 Million	101,100 Added 325.08%	132,200 $4.06 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $259,920 - $392,844	7,600 Added 32.34%	31,100 $1.06 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.